Since the lack of prognostic significance of cyclin A is mainly seen in patients with lymph node-negative breast cancer, it is possible that cyclin A plays a more important role in aggressive tumours and metastatic disease (Kuhling et al, 2003). This evidence concerns the gene CCNA2 and neoplasm.